Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential-Reference-Cited by-同舟云学术

Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential

Published:2020-07-10 Issue: Volume:8 Page:
ISSN:2296-634X
Container-title:Frontiers in Cell and Developmental Biology
language:
Short-container-title:Front. Cell Dev. Biol.

Author:

Perla Alexandre,Fratini Lívia,Cardoso Paula S.,Nör Carolina,Brunetto André T.,Brunetto Algemir L.,de Farias Caroline Brunetto,Jaeger Mariane,Roesler Rafael

Publisher

Frontiers Media SA

Subject

Cell Biology,Developmental Biology

Reference136 articles.

1. Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors.;Algar;PLoS One,2009

2. Combined treatments with a retinoid receptor agonist and epigenetic modulators in human neuroblastoma cells.;Almeida;Mol. Neurobiol.,2017

3. Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG.;Anastas;Cancer Cell,2019

4. The interplay of epigenetic marks during stem cell differentiation and development.;Atlasi;Nat. Rev. Genet.,2017

5. Epigenetic drugs for cancer and microRNAs: a focus on histone deacetylase inhibitors.;Autin;Cancers,2019

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PTCH1-mutant human cerebellar organoids exhibit altered neural development and recapitulate early medulloblastoma tumorigenesis;Disease Models & Mechanisms;2024-02-01

2. A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma;Cancer Research;2024-01-17

3. PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo;Scientific Reports;2024-01-03

4. Epigenetic dysregulation in brain tumors;Neuropsychiatric Disorders and Epigenetics;2024

5. MYC overexpression and SMARCA4 loss cooperate to drive medulloblastoma formation in mice;Acta Neuropathologica Communications;2023-11-02